Popular

XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial

January 23, 2023 The Wall Street Analyzer 0

Safe and Effective Dosing of XORLO™ […]

News Feed

Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies

January 18, 2023 The Wall Street Analyzer 0

ANN ARBOR, MI / ACCESSWIRE / January 18, 2023 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced a strategic restructuring of […]

Acutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer

January 9, 2023 The Wall Street Analyzer 0

CARLSBAD, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced preliminary […]

Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium

December 29, 2022 The Wall Street Analyzer 0

The AcQForce Flutter clinical study was submitted to the FDA as part of Acutus’ PMA submission for the AcQBlate Force Sensing Ablation Catheter […]

CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD

December 12, 2022 The Wall Street Analyzer 0

Drug Candidate, CQ-001 (cannabidiol “CBD” + IP formula), also demonstrated substantially reduced seizures at higher doses, with less CBD, compared to standard CBD.
[…]

XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics Study

November 29, 2022 The Wall Street Analyzer 0

XRX-OXY-101 Study will inform the dose choice in the upcoming Phase 3 Clinical Trial […]

Zomedica Announces Third Quarter 2022 Financial Results: $4.78 Million Revenue; 75% Gross Margin & $158.49 Million in Cash

November 15, 2022 The Wall Street Analyzer 0

ANN ARBOR, MI / ACCESSWIRE / November 14, 2022 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”, a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported consolidated financial results for […]

SCOTTIE RESOURCES EXTENDS STRIKE OF BLUEBERRY CONTACT ZONE TO 1.45 KILOMETERS AND REPORTS INTERCEPT OF 4.24 G/T GOLD OVER 16.95 METRES

November 9, 2022 The Wall Street Analyzer 0

VANCOUVER, BC, Nov. 8, 2022 /CNW/ – Scottie Resources Corp. (“Scottie” or the “Company“) (TSXV: SCOT) (OTCQB: SCTSF) (FSE: SR8) is pleased to report new assays on its Blueberry Contact Zone including an intercept of 20.3 g/t gold […]

News Feed

Pro-Dex, Inc. Announces Fiscal 2023 First Quarter Results

November 4, 2022 The Wall Street Analyzer 0

IRVINE, CA / ACCESSWIRE / November 3, 2022 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2023 first quarter ended September 30, 2022. The Company also filed its Quarterly Report on Form 10-Q […]

Knightscope Completes Acquisition of CASE Emergency Systems

October 21, 2022 The Wall Street Analyzer 0

Public Safety Innovator Accelerates Growth Nationwide […]